To understand the interaction between VWF and FVIII at a level where it can be used to guide the developments of improved therapies for patients with hemophilia A or VWD, more detailed information is needed, specifically on the flexible FVIII a3 region and its interaction with VWF. This evidence concerns the gene VWF and von Willebrand disease (hereditary or acquired).